Morgan Stanley Pathway Sm-Md Cp Eq ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Morgan Stanley Pathway Small-Mid Cap Equity ETF MSSM
Morningstar’s Analysis MSSM
Will MSSM outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 6.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Us Dollars | 1.62 | 11M | Cash and Equivalents |
Dynatrace Inc Ordinary Shares | 0.90 | 6M | Technology |
Ascendis Pharma AS | 0.72 | 5M | Healthcare |
Viasat Inc | 0.69 | 5M | Technology |
Veeco Instruments Inc | 0.63 | 4M | Technology |
KBR Inc | 0.62 | 4M | Industrials |
Rambus Inc | 0.54 | 4M | Technology |
Haemonetics Corp | 0.53 | 4M | Healthcare |
TechnipFMC PLC | 0.52 | 4M | Energy |
Plexus Corp | 0.52 | 4M | Technology |